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Purpose. The acidic microclimate in poly(D, L-lactide-co-glycolide)
50/50 microspheres has been previously demonstrated by our group
as the primary instability source of encapsulated bovine serum albu-
min (BSA). The objectives of this study were to stabilize the encap-
sulated model protein, BSA, and to achieve continuous protein re-
lease by using a blend of: slowly degrading poly(D, L-lactide) (PLA),
to reduce the production of acidic species during BSA release; and
pore-forming poly(ethylene glycol) (PEG), to increase diffusion of
BSA and polymer degradation products out of the polymer.
Methods. Microspheres were formulated from blends of PLA (Mw
145,000) and PEG (Mw 10,000 or 35,000) by using an anhydrous
oil-in-oil emulsion and solvent extraction (O/O) method. The poly-
mer blend composition and phase miscibility were examined by FT-
IR and DSC, respectively. Microsphere surface morphology, water
uptake, and BSA release kinetics were also investigated. The stability
of BSA encapsulated in microspheres was examined by losses in pro-
tein solubility, SDS-PAGE, IEF, CD, and fluorescence spectroscopy.
Results. PEG was successfully incorporated in PLA microspheres
and shown to possess partial miscibility with PLA. A protein loading
level of 5% (w/w) was attained in PLA/PEG microspheres with a
mean diameter of approximately 100 mm. When PEG content was
less than 20% in the blend, incomplete release of BSA was observed
with the formation of insoluble, and primarily non-covalent aggre-
gates. When 20%–30% PEG was incorporated in the blend formu-
lation, in vitro continuous protein release over 29 days was exhibited.
Unreleased BSA in these formulations was water-soluble and struc-
turally intact.
Conclusions. Stabilization and controlled relaease of BSA from PLA/
PEG microspheres was achieved due to low acid and high water
content in the blend formulation.
KEY WORDS: poly(D, L-Lactide); poly(ethylene glycol); bovine se-
rum albumin; microspheres.
INTRODUCTION
Biodegradable polymers have been investigated exten-
sively to provide controlled release from days to months for
therapeutic proteins and vaccine antigens (1). The drug re-
lease mechanism from poly(D, L lactide-co-glycolide)
(PLGA) microspheres can be based on diffusion, polymer
degradation, and or osmotically mediated events (1). A major
limitation of this delivery system is the common formation of
an acidic microclimate within the polymer device during re-
lease due to polymer degradation, which leads to destabiliza-
tion of encapsulated acid-labile bio-macromolecules. Previ-
ous work in our lab demonstrated that the acidic microclimate
and intermediate water content existing in PLGA 50/50 de-
livery systems were the major causes of instability of encap-
sulated bovine serum albumin (BSA) (2). By co-
encapsulating poorly water-soluble basic additives such as
Mg(OH)2, the acidic microclimate was neutralized and en-
capsulated BSA was stabilized for more than 1 month (2,3).
Another two therapeutic proteins, recombinant human basic
fibroblast growth factor (bFGF) and bone morphogenetic
protein-2 (BMP-2) also showed enhanced stability in the
polymer following neutralization of the acidic microclimate
(2).
In this study, instead of neutralizing the acidic microcli-
mate, a strategy to avoid acid build-up was devised. A blend
of: slowly degrading poly(D, L-lactide) (PLA), to reduce the
production of acidic species during protein release; and wa-
ter-soluble poly(ethylene glycol) (PEG), to increase diffusion
of the protein and polymer degradation products, were used
to modify the microsphere microclimate and protein release
behavior. PLA has a much slower degradation rate than
PLGA 50/50 due to its higher hydrophobicity and the steric
hindrance for the water attack on the ester bond introduced
by the methyl group of lactic acid (4). Likewise, PLA has
been shown to produce acidic by-products and release mono-
mers at a reduced rate relative to the glycolic-containing co-
polymers (5,6). For example, the monomer content released
from PLA has been reported to be ∼14-fold less than PLGA
50/50 over a 4-week incubation in buffered media (6). How-
ever, like PLGA 50/50, PLA will still cause an eventual acid
build-up. In addition, its slow degradation may lead to slow
and discontinuous release of proteins and its strong hydro-
phobicity has been suggested to possibly denature proteins
(7). Therefore, the second component, relatively more hydro-
philic PEG, is introduced into PLA to adjust the microsphere
acidity, hydrophobicity, and permeability. PEG is nontoxic
and soluble in numerous organic solvents and water. During
release, PEG can be soluble in the release medium, resulting
in the formation of swollen structure with high water content
in the polymer blend. This swollen polymer structure is ex-
pected to increase exchange of polymer degradation products
with the surrounding medium, minimizing the risk of acid-
induced protein degradation. Moreover, before excessive
PLA degradation occurs, aqueous pores formed by PEG dis-
solution are expected to increase diffusion of the encapsu-
lated protein, providing continuous protein release.
The use of polymer blends has been an appealing ap-
proach for controlled drug delivery. PLGAs have been
blended with various poloxamers and PEGs to improve pro-
tein delivery capacity and obtain controlled release profiles
(8–12). Moreover, blends of PLGA with PEG fabricated by a
water-in-oil-in-oil method showed improved ovalbumin load-
ing and stability (12). However, in the above formulations,
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incomplete release and aggregation of the protein from mi-
crosphere formulations were still observed.
The PLA-PEG microspheres studied here were prepared
by an oil-in-oil emulsion and solvent extraction (O/O)
method, instead of the most commonly used water-in-oil-in-
water double emulsion and solvent evaporation (W/O/W)
method. The former approach generally results in high pro-
tein entrapment levels and superior protein stability due to
the absence of water (13,14). A model protein antigen, bovine
serum albumin (BSA), was selected and encapsulated in the
polymer blend. Acid-labile BSA has been used as a model
protein to examine the acidic microclimate in PLGA micro-
spheres (2). In addition, its structure and antigenicity are well
documented (15,16). In this report, we describe the stabiliza-
tion and slow release of BSA from PLA-PEG microspheres
without any observed acid-induced instability.
MATERIALS AND METHODS
Chemicals
Poly(D, L-lactide) with inherent viscosity of 1.07 dl/g
(Lot 112-15-1, Mw 145,000; polydispersity 1.50) in CHCl3 was
from BPI (Birmingham, AL). Poly(ethylene glycol) with mo-
lecular weight 10,000 (Lot 14904BU) and 35,000 (Lot 403392)
was obtained from Aldrich Chem. Co. (Milwaukee, WI) and
Fluka (Milwaukee, WI), respectively. Bovine serum albumin
(A-3059, Lot 32H0463) was purchased from Sigma Chemical
Co. (St. Louis, MO). Protein molecular weight and pI stan-
dards for electrophoresis were from Pharmacia LKB (Piscat-
away, NJ). All other biochemicals and chemicals were of ana-
lytical grade or purer and obtained from commercial suppli-
ers.
Microsphere Preparation
The polymeric microspheres were prepared by an anhy-
drous O/O method. First, PLA and PEG at various weight
ratios were co-dissolved in the acetonitrile at a total polymer
concentration of 20% (w/v). Sieved BSA dry powder (< 20
mm) was suspended in acetonitrile-polymer solution and ho-
mogenized at 15,000 rpm in an ice bath. Then the antigen
suspension was added drop-wise into the continuous phase
(cottonseed oil containing 1.6% (W/V) span 85) stirred at 750
rpm with an overhead stirrer. After 5 h, petroleum ether (b.p.
50–110°C) was poured into the cottonseed oil bath to extract
the remaining acetonitrile from the polymer. After an addi-
tional 15 min of stirring, the microspheres were filtered,
washed with 250 ml of petroleum ether and lyophilized.
Microsphere Characterization
Morphology and Particle Size Determination
The microspheres were coated with gold-palladium by
using Pelco Model 3 Sputter Coater 91000 (Ted Pella, Inc.,
Redding, CA). Surface morphology of the microspheres was
examined by a Philips XL Scanning Electron Microscope
(FEI, Deutschland Gmb H, Germany). Particle size was es-
timated by averaging diameters of 50 microspheres.
Polymer Composition Analysis by FTIR
The composition of microspheres prepared from differ-
ent blends of PLA and PEG was analyzed by infrared spec-
troscopy. A Nicolet protégé 460 (Thermo Nicolet, Madison,
WI) was used to obtain the spectra (32 scans per sample, over
600–4000 cm−1) for the samples. A series of PLA and PEG
physical mixtures with different weight ratios was used to
make a calibration curve. Samples were dissolved in chloro-
form and casted into a sodium chloride cell. The composition
of the microparticles was estimated by comparing peak height
ratios corresponding to the carbonyl (C 4 O) band of PLA at
1757 cm−1 and the CH2 band at 2876 cm
−1 due to the PEG
component, and assuming a negligible content of span 85 sur-
factant in microspheres.
Polymer Phase Behavior Analysis by DSC
Samples (3–5 mg) were loaded into aluminum pans and
DSC thermograms were recorded by a Perkin-Elmer DSC 7
Differential Scanning Calorimeter (Norwalk, CT). Nitrogen
gas was the sweeping gas and the heating rate was 20°C/min.
Determination of Microsphere Loading
The amount of antigen encapsulated in microspheres was
determined by recovering the protein from the microspheres.
First, acetone was added to the microspheres to dissolve the
polymer. The mixture was vortexed, centrifuged, and then
supernatant was removed. After the removal of polymer was
repeated three times, the remaining protein pellet was air
dried and reconstituted in phosphate buffer saline pH 7.4
containing 0.02% Tween 80t (PBST) and protein content was
determined by the Coomassie Plus method (Pierce Chem
Co., Rockford, IL)
Evaluation of Model Antigen Release from Microspheres
Samples of 10 mg microspheres were suspended in 1 ml
PBST. The suspension was incubated at 37°C under mild agi-
tation. At pre-selected intervals, release media were removed
for determination and replaced with fresh buffer. The amount
of protein released was assayed by the Coomassie Plus
method (Pierce). At the end of release, microspheres were
collected and remaining soluble protein in the microspheres
was analyzed as described in the section “Determination of
Microsphere Loading.” Any insoluble protein aggregates
were collected by centrifugation and reconstituted in dena-
turing agent (8 M Urea or 6 M Guanidine-HCl (GnCl)). De-
termination of any aggregates soluble in denaturing agent
gave the amount of non-covalently bonded aggregates. With
the further addition of reducing agent (10 mM DTT + 1 mM
EDTA), any disulfide-bonded aggregates were dissolved. The
total dissolved portion in denaturing and reducing agents
gave the total amount of non-covalent and disulfide-bonded
aggregates.
pH Change in the Release Medium During Release
The pH of the release medium was monitored by a Corn-
ing 430 pH meter (Corning, NY) at each sampling interval.
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Water Uptake of Microspheres
After incubation at 97% relative humidity and 37°C, mi-
crospheres were taken out and weighed immediately. The
water uptake of microspheres was estimated by:
Water uptake (%) 4 (W1−W2)/W2×100%
Where W1 and W2 are the weights of the hydrated micro-
spheres and microspheres before incubation, respectively. No
corrections were made for inter-particle water content in W1
or the water content within lyophilized microspheres in W2.
Structural Analysis of Encapsulated BSA and GnCl-induced
Unfolding of BSA
At the end of release period, the integrity of remaining
BSA in the polymer was determined by both sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
isoelectric focusing (IEF) analysis, which were performed on
a Pharmacia PhastSystem (Pharmacia Biotech, Uppsala, Swe-
den) according to the file no. 110 and 100 in the Phastsys-
tem™ User Manual, respectively. In both analyses, Coo-
massie staining file no. 200 was used. The secondary structure
of antigen samples was determined by measuring circular di-
chroic (CD) spectra. The spectra were taken with a J-500A
Jasco spectropolarimeter (Hachioji, Japan) at room tempera-
ture. The tertiary structure of protein samples was analyzed
by measuring the intrinsic fluorescence emission spectra.
Fluorescence emission spectra (300–500 nm for BSA) were
obtained on a Perkin-Elmer LS50B luminescence spectrom-
eter (Norwalk, CT) scanned at 240 nm/min. The excitation
wavelength for BSA was set to 295 nm. Details of these pro-
cedures were as described previously (17).
For GnCl unfolding of BSA, 100 mg/ml of BSA stock
solution in the presence or absence of 5-fold weight excess
PEG 10,000 or PEG 35,000 were prepared in 30 mM MOPS
buffer (pH 7.0). BSA stock solution was diluted in various
concentrations of GnCl to reach the final protein concentra-
tion of 6.25 mg/ml. The fluorescence of BSA at 345 nm was
determined when the protein was excited at 280 nm by using
Fluromax-2 fluorometer (Instrument S. A., Inc., NJ). The un-




where FN and FU are the fluorescence of the native (in ab-
sence of GnCl) and fully unfolded states (in concentrated
GnCl), respectively; and Fi is the protein fluorescence at the
ith concentration of GnCl.
RESULTS AND DISCCUSION
Microsphere Composition and Phase Behavior Analysis
In Fig. 1, the IR spectra of blank microspheres prepared
from pure PEG, pure PLA (i.v. 4 1.07 dl/g), and a PLA/PEG
blend are displayed. A broad band at 2876 cm−1 and a peak at
1757 cm−1 were assigned to the CH2 stretching on the PEG
unit and the carbonyl group (C4O) of PLA, respectively.
Both characteristic peaks for CH2 and C4O appeared in the
IR spectrum of the blend of PLA and PEG. By estimating the
PEG content in the blend with a calibration curve generated
from PLA and PEG physical mixtures with different weight
ratios, complete incorporation of PEG in PLA matrix by the
O/O encapsulation method was indicated (data not shown).
In Table I, the DSC thermograms of prepared blank mi-
crospheres are shown. PLA exhibited a Tg of roughly 53.5°C
and PEG showed a Tm of 71°C. In the PLA and PEG micro-
sphere blend, down shifts in both Tg and Tm of 7-11°C and
8-10°C, respectively, were observed, indicating partial misci-
bility between PLA and PEG.
Microsphere Morphology
As seen in Fig. 2, after preparation, microspheres with
different weight ratios of PLA and PEG had spherical and
smooth surfaces. An average size of ∼100 mm was recorded
for these microsphere preparations. After 35 days of incuba-
tion, microspheres prepared from 100% PLA remained intact
with a smooth surface. With the blend of PEG, the micro-
sphere structure still remained intact, but a small amount of
pores appeared on the PLA/PEG microspheres surface. With
higher PEG blend, more pores became visible. In addition,
the microsphere surface showed indentations, which may
have occurred during drying of the particles before analysis.
The SEM images suggested that the incorporation of PEG
into PLA created more channels in the microspheres, which
may have increased the permeability to the encapsulated pro-
tein and polymer degradation products. In addition, the mi-
crosphere surface likely consisted of a PLA-rich phase,
whereas the interior of microspheres was likely PEG-rich.
Otherwise, more pores created by PEG solubilization would
be expected on the microsphere surface. The PLA-rich sur-
face phenomenon is possibly due to the higher hydrophobic-
ity and longer chain of PLA, which could have caused selec-
tive PLA precipitation at the surface during the O/O micro-
Fig. 1. IR spectra of (A) PEG 35,000 microspheres, (B) PLA (i.v. 4
1.07 dl/g) microspheres, and (C) PLA/PEG 35,000 (80/20) micro-
spheres.
Table I. The Effect of PLA and PEG Contents on Polymer Thermo-




PEG 35 kD Tg (°C) Tm (°C)
PEGa 100 — 71.1
PLAa 0 53.5 —
PLA/PEGa 10 44.5 62
PLA/PEGa 20 42.3 63.1
PLA/PEGa 30 46.5 61.4
a All the examined microspheres were blank microspheres. Total
polymer concentration (w/v) was 20%.
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sphere preparation. Further surface analysis would be
required for a definitive conclusion.
Release Kinetics and Stability of BSA in the
PLA/PEG Microspheres
To investigate the effect of PEG in the PLA/PEG mi-
crospheres, microspheres with different weight ratios of PEG
10,000 to PLA were prepared and the BSA controlled release
was monitored in PBST at 37°C. Theoretical BSA loading of
all these formulations was 5% and encapsulation efficiency
was invariably between 90% and 100%. As seen in Fig. 3A,
when PEG content was less than 10% of polymer weight,
similar release kinetics of BSA from microspheres was ob-
served and less than 45% of BSA was released after a 4-week
incubation. When PEG content was raised to 20%, the total
releasable amount of protein was significantly increased to
75%. The effect of PEG molecular weight on protein release
was also evaluated. As seen in Fig. 3B, BSA had almost iden-
tical release kinetics in microspheres irrespective of whether
PEG 10,000 and PEG 35,000 was used (the weight ratio of
PEG:PLA was 20:80). When PEG 35,000 content was in-
creased to 30% in PLA/PEG microspheres, a higher burst
release of BSA was observed.
The residual BSA remaining in these devices after the
4-week release interval (45 days for formulation without
PEG, i.e., formulation o) was analyzed and listed in Table II.
For the formulation o, of the original encapsulated protein,
15% was still water-soluble and 25% of BSA had become
water-insoluble aggregates in the residue. Most of the aggre-
gates were soluble in a denaturing solvent (6 M urea), indi-
cating their non-covalent character. When 5% of PEG was
incorporated in PLA (formulation a), soluble BSA remaining
in microspheres was increased to 30%, and the non-covalent
aggregates were 41% of the original encapsulated BSA.
When PEG content was increased to 10% (formulation b),
36% of the protein formed insoluble aggregates. Besides non-
covalent aggregates, a small fraction of disulfide-bonded ag-
gregates (soluble in 10 mM DTT) was also formed. However,
no insoluble BSA aggregates were observed in formulations
containing 20% PEG or more.
The integrity of the soluble BSA recovered from the
polymer (29-day incubation) was further examined by SDS-
PAGE. As seen in Fig. 4A, some faint peptide fragments
were observed in lanes 6 and 7 (formulations a and b), indi-
cating mild peptide bond hydrolysis occurred during incuba-
tion. In contrast, soluble BSA recovered from formulations
containing more than 20% PEG showed a very similar band
with standard BSA and no degradation product bands were
noticeable. Soluble BSA recovered from formulations c, d,
and e was further examined by IEF. No pI alterations in BSA
were observed in these samples. Likewise, secondary and ter-
tiary structure of BSA was virtually identical to the standard
BSA control. Hence, the structure of BSA in formulations c,
d, and e was retained within the polymer for nearly one
month.
Mechanisms of BSA Stabilization in the PLA/PEG
Microspheres
One-month continuous release of stable BSA from mi-
crospheres was achieved when PEG content in the PLA/PEG
blends was above 20% or above. As identified previously, an
Fig. 2. The SEM images of (A) PLA (i.v. 4 1.07 dl/g) microspheres, (B) PLA/PEG 35,000 (90/10) microspheres, and (C) PLA/PEG
35,000 (80/20) microspheres before and after incubation in the release medium.
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acidic microclimate and intermediate moisture levels are the
two major factors that cause non-covalent aggregation and
peptide-hydrolysis of BSA in PLGA 50/50 microspheres.
Does the blend of PEG with PLA improve the microclimate
as we designed, i.e., by avoiding the acidic microclimate and
increasing the water content to stabilize BSA encapsulated in
microspheres?
To address this question, we first examined the pH
change of the release medium when the PLA/PEG formula-
tions were incubated at 37°C and PBST (pH 7.4). Unlike
PLGA 50/50, which caused a dramatic pH drop in the release
medium after a 4-week incubation (3), a relatively neutral pH
was retained in the release medium for both PLA and PLA/
PEG formulations. However, a slightly lower pH in the re-
lease medium incubated with PLA/PEG formulation relative
to that in PLA was observed (∼ 0.1–0.2 pH unit difference).
This result indicated that some acidic degradation products
were able to diffuse out of polymer device through the water
channels formed by PEG in PLA/PEG formulation. In addi-
tion, by using a previously reported method (for hydronium
activity aH* determination of polymer solution in the mixture
of ACN and water) (18), the paH* inside formulation d before
and after 30-day incubation was determined as 6.5 and 5.4,
respectively (data not shown), suggesting a very small accu-
mulation of acid in the polymer. In contrast, PLGA 50/50
microspheres were reported to reach paH* ∼3 after a similar
incubation time (19). These results demonstrated that acid
build-up was largely reduced in the PLA/PEG blend formu-
lation.
The water content difference in formulations during re-
lease was compared by performing a water uptake kinetic
study of microspheres at 97% [RH]. Under controlled humid-
ity, microspheres will adsorb water vapor and potential water
uptake of different formulations during release can be pre-
dicted and compared. As seen in Fig. 5B, PEG 35,000 showed
a strong water uptake. On the second day, the water content
in PEG 35,000 blank microspheres was almost 120% of the
dry microsphere weight, whereas PLA blank microspheres
showed insignificant water uptake. Upon blending PEG in
the formulation, the water uptake rate was significantly in-
creased compared to PLA blank microspheres. The higher
the PEG content, the higher the increase in water uptake.
Microspheres containing 20% PEG had almost twice the
amount of water relative to those with 10% of PEG in the
humid environment. Therefore, when microspheres are incu-
bated in the release medium, higher water content in the
PLA/PEG blend than in PLA is expected. The presence of
5% BSA did not increase water uptake rate significantly in
the blend formulation. The water uptake in the blend was
likely overwhelmed by the strong water sorption by PEG.
The above results demonstrated that a less acidic and
more hydrophilic microenvironment was achieved in the
PLA/PEG blend. Maintenance of a relatively neutral micro-
climate in PLA/PEG blend formulation can be attributed to
the following. First, few acidic species were produced during
early incubation due to the slow degradation of PLA. The
rate constant of PLA degradation at 37°C in water has been
reported to be roughly 0.012 day−1, much slower than PLGA
















o — 0 36 ± 1e 15 ± 1e 22 ± 1e 25 ± 2e 76 ± 2e
a 10 kD 5 44.6 ± 0.3 30 ± 2 41 ± 2 41 ± 7 116 ± 7
b 10 kD 10 40.4 ± 0.3 39 ± 2 26 ± 4 36 ± 4 115 ± 4
c 10 kD 20 73.2 ± 0.3 37 ± 4 — — 110 ± 4
d 35 kD 20 75.5 ± 0.3 30.2 ± 0.2 — — 106 ± 1
e 35 kD 30 82.3 ± 0.2 30 ± 2 — — 112 ± 2
a Theoretical protein loading was 5%; PLA (i.v. 4 1.07 dl/g) was used in the formulation and the total polymer concentration (w/v) was 20%.
b Soluble in PBST.
c Soluble in denaturing agents (8 M Urea).
d Soluble in combined denaturing and reducing agents (8 M Urea and 10 mM DTT).
e The BSA release study from the PLA specimen was performed over 45 days and the residue was recovered after this time.
Fig. 3. The effect of PEG content and molecular weight in the PLA/
PEG blend on the release kinetics of BSA. (A) PEG 10,000 content
was 0% (d), 5% (j), 10% (m), and 20% (.); (B) PEG molecular
weight and content were 20% PEG 10,000 (j) and 20% PEG 35,000
(d), 30% PEG 35,000 (m). (average ± SD, n 4 3)
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50:50, 75:25, 85:15 with rate constants of 0.103, 0.055, and
0.026 day−1, respectively (4). In addition, prior to hydration,
the polymer acid content was determined as 21 and 4.2 nmol/
mg for the PLGA 50/50 used in our previous study and PLA
used here, respectively (5). Therefore, the total amount of
acidic species in PLA should be less than PLGA either during
encapsulation or during hydration. Second, the blend of PEG
with PLA significantly increased the water content in the for-
mulation, which is expected to dilute the acidic species even
further. Third, the dissolution of PEG in the release medium
may create more water channels, thereby increasing the dif-
fusion for acidic species out of the polymer and for buffering
species into the PLA matrix.
By the above three mechanisms, a less acidic microcli-
mate will be formed in the PLA/PEG blend. When PEG
content is 10% or less in the blend formulations, non-covalent
aggregates and peptide fragments of BSA were still observed.
This is likely due to regional acidity in the polymer. In certain
regions, slowly produced polymer degradation products could
not be diluted or diffuse out of the polymer because of insuf-
ficient water channels, resulting in regionally low pH. With
increasing amount of PEG in the blend, a more neutral mi-
croclimate was gradually attained. Although slight pH de-
creases within the polymer was still detected in the blend
containing 20% PEG, it was not significant enough to cause
non-covalent aggregation and peptide-hydrolysis of BSA.
The stabilization of BSA in the PLA/PEG microspheres
can also be attributed in part to the increased water content in
the formulation. It was reported that the aggregation of BSA
at acidic pH (pH 4 2) exhibited a pronounced bell-shape
with maximum aggregation at roughly 100g water/100 g dry
protein. When water content was increased to 500%–1000%,
Fig. 4. BSA is stabilized in PLA-PEG microsphere blends with PEG content $ 20%. All BSA analysis was on protein recovered from
the following polymer samples after 29 days of release. (A) Reducing SDS-PAGE. Lane 1: PLA/PEG35,000 (70/30); Lane 2: PLA/
PEG35,000 (80/20); Lane 3: PLA/PEG10,000 (80/20); Lane 4: standard BSA; Lane 5: molecular weight marker; Lane 6: PLA/
PEG10,000 (95/5); and Lane 7: PLA/PEG10,000 (90/10). (B) IEF. Lane 1: PLA/PEG10,000 (80/20); Lane 2: high pI marker; Lane 3:
low pI marker; Lane 4: standard BSA; Lane 5: PLA/PEG35,000 (80/20); and Lane 6: PLA/PEG35,000 (70/30). (C) CD spectra. BSA
standard (••••), PLA/PEG35,000 (80/20) (•—•); PLA/PEG35,000 (70/30) (••–••); and PLA/PEG10,000 (80/20) (—). (D) Fluorescence
spectra. BSA standard (••••), PLA/PEG35,000 (80/20) (•—•); PLA/PEG35,000 (70/30) (••–••); and PLA/PEG10,000 (80/20) (—).
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aggregation of BSA at pH 2 was declined sharply (20). In the
blend formulation containing 20% of PEG, when incubated
at 97% R.H. for 1 week, the water content in the micro-
spheres was ∼25%. Assuming all the water is available for
BSA (BSA loading is 5%) in microspheres, the water content
of BSA is ∼500%. During release, the water content in mi-
crospheres was expected to be higher than 500%. Thus, in
addition to the minimal acid content, the aggregation of BSA
was minimized by the high amount of imbibed water in the
microenvironment.
A final consideration is that PEG may interact favorably
with the hydrophobic side chains of protein molecules ex-
posed upon unfolding (21). It was reported that PEG of low
Mw 1000 and 4000 interacts favorably with such regions of
human serum albumin, leading to a stabilization of the un-
folded state (21). To test any potential interaction of high Mw
PEG with BSA, the GnCl unfolding curve of BSA with the
addition of PEG 10,000 and PEG 35,000 (the weight ratio of
BSA to PEG was 1:5) was determined by fluorescence spec-
troscopy. As seen in Fig. 6, similar unfolding curves were
observed in these three preparations. These data suggest that
the conformational stability of BSA was, therefore, unaf-
fected by the addition of PEG 10,000 and PEG 35,000, as
demonstrated by CD and fluorescence spectroscopy previ-
ously.
CONCLUSIONS
Based on the fact that acidic microclimate and interme-
diate moisture levels were the major factors that cause BSA
instability, a PLA/PEG blend formulation with low acid and
high water content was devised. By using the PLA/PEG
blend, a one-month continuous release of BSA was achieved
with the absence of insoluble aggregates and peptide hydro-
lysis. This formulation approach may be generally applicable
for encapsulation of other acid-labile proteins and vaccine
antigens.
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